The treatment of malignant pleural mesothelioma (MPM) has evolved in the past 20 years. Although controversy still exists with regard to standard care, significant advances have been made in diagnosis, imaging, staging, patient selection, chemotherapy, surgical technique, and radiotherapy. Before 1990, pathologic diagnosis was less precise. Therefore, older series included adenocarcinomas and sarcomas inadvertently diagnosed as epithelioid and sarcomatoid mesotheliomas, respectively, leading to inaccurate survival information. Table 1 Table 1 shows some of the largest and most relevant studies in MPM.
1 x 1 Ruffie, P, Feld, R, Minkin, S et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 322 patients. J Clin Oncol. 1989; 7: 1157–1168 Crossref | PubMed | Scopus (299) | Google Scholar See all References
, 2 x 2 Alberts, AS, Falkson, G, Goedhals, L et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol. 1988; 6: 527–535 Crossref | PubMed | Scopus (191) | Google Scholar See all References
, 3 x 3 Butchart, E, Ashcroft, T, Barnsley, W et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax. 1976; 31: 15–24 Crossref | PubMed | Scopus (379) | Google Scholar See all References
, 4 x 4 Sugarbaker, DJ, Flores, RM, Jaklitsch, MT et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long- term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999; 117: 54–65 Abstract | Full Text | Full Text PDF | PubMed | Scopus (730) | Google Scholar See all References
, 5 x 5 Rusch, VW and Venkatraman, ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 1999; 68: 1799–1804 Abstract | Full Text | Full Text PDF | PubMed | Scopus (192) | Google Scholar See all References
, 6 x 6 Herndon, JE, Green, MR, Chahinian, AP, Corson, JM, Suzuki, Y, and Vogelzang, NJ. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest. 1998; 113: 723–731 Crossref | PubMed | Scopus (366) | Google Scholar See all References
, 7 x 7 Aziz, T, Jilaihawi, A, and Prakash, D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg. 2002; 22: 298–305 Crossref | PubMed | Scopus (96) | Google Scholar See all References
, 8 x 8 Lee, TT, Everett, DL, Shu, HG et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc. 2002; 124: 1183–1189 Abstract | Full Text | Full Text PDF | PubMed | Scopus (87) | Google Scholar See all References
, 9 x 9 Maggi, G, Casadio, C, Cianci, R, Rena, O, and Ruffini, E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2001; 19: 346–350 Crossref | PubMed | Scopus (66) | Google Scholar See all References
, 10 x 10 Vogelzang, NJ, Rusthoven, JJ, Symanowski, J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003; 21: 2636–2644 Crossref | PubMed | Scopus (1868) | Google Scholar See all References